Skip to main content
. 2021 Apr 22;12(2):117–128. doi: 10.1007/s13167-021-00239-0

Table 4.

Differential metabolites of serum between patients with ESRD and healthy controls

Metabolic Pathway Metabolites Mean (ESRD) Mean
(HC)
Fold change Log_fold change AUC value
Glycine, serine, and threonine metabolism Glycine 1.9834 0.6171 3.214 1.684 0.972
l-Serine 1.3163 0.1549 8.497 3.087 0.995
l-Allothreonine 3.0007 0.4912 6.109 2.611 0.971
Phenylalanine metabolism l-Phenylalanine 46.5813 19.7719 2.356 1.236 0.975
ortho-Hydroxyphenylacetic acid 15.8486 0.3832 41.359 5.370 1.000
Phenylacetic acid 15.8486 0.3832 41.359 5.370 0.997
Phenylacetylglutamine 174.1466 0.9897 175.951 7.459 1.000
4-Hydroxybenzoic acid 13.9005 0.0890 156.181 7.287 1.000
p-Hydroxyphenylacetic acid 2.1442 0.0570 37.632 5.234 0.993
Pyrimidine metabolism Cytosine 2.0971 0.1987 10.556 3.400 1.000
Deoxyribose 1-phosphate 542.9885 12.8789 42.161 5.398 0.983
Uracil 6.0958 1.5430 3.951 1.982 0.995
Pseudouridine 34.0287 1.6156 21.063 4.397 1.000
Arginine and proline metabolism Creatinine 75.2642 2.7376 27.493 4.781 1.000
Citrulline 4.3835 0.0979 44.772 5.485 1.000
l-Proline 38.7071 12.2175 3.168 1.664 0.975
4-Hydroxyproline 4.1395 0.5685 7.281 2.864 0.970
4-Acetamidobutanoic acid 10.1351 0.0577 175.635 7.456 1.000
N-Acetylglutamic acid 0.9101 0.0517 17.611 4.138 1.000

ESRD, end-stage renal disease; HC, healthy controls; AUC, area under curve